Tt International Asset Management LTD Gilead Sciences, Inc. Transaction History

Tt International Asset Management LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $2.31 Million - $2.63 Million	-40,717 Closed	0 $0
Q2 2020 Aug 07, 2020	SELL	$72.34 - $84.0 $2.62 Million - $3.04 Million	-36,212 Reduced 47.07%	40,717 $3.13 Million
Q1 2020 May 13, 2020	BUY	$62.63 - $80.22 $4.82 Million - $6.17 Million	76,929 New	76,929 $5.75 Million

1,926

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Tt International Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Tt International Asset Management LTD with notifications on news.